SCHEMBL9402352

SCHEMBL9402352

CCCCc1nnc(SCc2cccc(C(=O)OC)c2)n1Cc1ccc(NC(=O)c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9402361 0.93 — —
SCHEMBL9402346 0.93 — —
SCHEMBL9402376 0.90 — —
SCHEMBL9402243 0.90 — —
SCHEMBL9402277 0.88 — —
SCHEMBL9402202 0.88 — —
SCHEMBL9402348 0.88 — —
SCHEMBL9402255 0.88 — —
SCHEMBL9402493 0.88 — —
SCHEMBL9402496 0.87 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5336778-A Substituted triazoles as angiotensin II antagonists MERCK & CO., INC. (US) 1994-08-09 — — US disclosed
Send feedback